Výsledky vyhledávání - Jennifer G. Robinson
- Zobrazuji výsledky 1 - 20 z 97
- Přejít na další stránku
-
1
-
2
-
3
Safety of Aggressive Lipid Management Autor Michael H. Davidson, Jennifer G. Robinson
Vydáno 2007Revisão -
4
-
5
-
6
-
7
Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction Autor Julie C. Lauffenburger, Jennifer G. Robinson, Christine U. Oramasionwu, Gang Fang
Vydáno 2013Artigo -
8
Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS) Autor Eric M. Ammann, James V. Pottala, Jennifer G. Robinson, Mark A. Espeland, William S. Harris
Vydáno 2017Artigo -
9
-
10
-
11
-
12
Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosu... Autor Jennifer G. Robinson, Helen M. Colhoun, Harold Bays, Peter H. Jones, Yunling Du, Corinne Hanotin, Stephen Donahue
Vydáno 2014Artigo -
13
-
14
Association of Low‐Density Lipoprotein Cholesterol Levels with More than 20‐Year Risk of Cardiovascular and All‐Cause Mortality in the General Population Autor Shuang Rong, Benchao Li, Liangkai Chen, Yangbo Sun, Yang Du, Buyun Liu, Jennifer G. Robinson, Wei Bao
Vydáno 2022Artigo -
15
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODY... Autor Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen M. Colhoun
Vydáno 2015Artigo -
16
-
17
-
18
First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis Autor Brittney M. Donovan, Nichole Nidey, Elizabeth A. Jasper, Jennifer G. Robinson, Wei Bao, Audrey F. Saftlas, Kelli K. Ryckman
Vydáno 2018Revisão -
19
Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data Autor Naveed Sattar, David Preiss, Jennifer G. Robinson, C. Stephen Djedjos, Mary Elliott, Ransi Somaratne, Scott M. Wasserman, Frederick J. Raal
Vydáno 2016Revisão -
20
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cholesterol
Endocrinology
Biology
Confidence interval
Pathology
Lipoprotein
Disease
Hazard ratio
Cardiology
Diabetes mellitus
Proportional hazards model
LDL receptor
PCSK9
Statin
Alternative medicine
Apolipoprotein A1
Environmental health
Genetics
Placebo
Biochemistry
Ezetimibe
Sociology
Alirocumab
Randomized controlled trial
Cohort
Demography
Gastroenterology
Gene